drug
coagulation factor VIIa (recombinant)
Marketedupdated 4mo agoby Hema Biologics LLC
Approvedcommunity read0 votes
indications
investigational
Hemophilia
all catalysts(0)
nothing on the calendar yet
Trials studying coagulation factor VIIa (recombinant)
- phase3A Phase 3 Study of the Safety and Efficacy of Coagulation Factor VIIa (Recombinant) for the Prevention of Excessive Bleeding in Patients With Congenital Hemophilia A or B With Inhibitors to Factor VIII or IX Undergoing Elective Major Surgical Procedures SCOPE HIM
- —Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT®
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 8h ago
Found something off?
comments(0)
5-min edit window · permanent after that